LAG3 and melanoma: Thus, our current study explores whether the expression of four checkpoint markers (PD-L1, PD-1, LAG-3, and TIM-3) differs in extracranial melanomas versus the subsequent brain metastases, which may shed further light on the mechanism behind CNS-mediated immune suppression.